2542

Longevity risk seeks investor appeal

The LLMA's new indices promise a more tradable market in longevity risk, with greater appeal to investors, according to market players. But the market remains stuck in a "chicken and egg" situation on liquidity. Lorna Davies reports

2354

LLMA launches longevity indices

Four indices will be launched on Bloomberg platform later this year

2340

Hyping up the hedge

Aegon's €12bn longevity swap last month appeared to be the deal that would finally kick-start the heavily-hyped longevity risk transfer business. But the finer details reveal more marketing spin than substance. Sarfraz Thind investigates

2216

Talbot CEO becomes new LMA chairman

Rupert Atkin will take up role in February

1933

A traded market for longevity risk will take time

There are lots of obstacles to developing a market in longevity. Despite a few significant deals, there's "not an avalanche of interest" one expert says. Lorna Davies sounds out opinion.

1583

Solvency II: to delay or not to delay?

A delay to Solvency II appears inevitable, but there are competing views as to how this should be achieved. Michael Faulkner reports on the implications of a postponement.

1424

J.P. Morgan transfers longevity index to LLMA

LLMA plans to launch own mortality index

1156

Aviva joins the Life and Longevity Markets Association

Aviva has joined the Life & Longevity Markets Association, bringing the LLMA's membership to eleven.

1038

LMA warns of "triple regulation" of Lloyd's market

Proposed UK financial services regulatory system too banking-focused